Man with cystic fibrosis to run London Marathon
A 19-year-old with cystic fibrosis (CF) is aiming to run the London Marathon to raise money for charity and awareness for the ...
Mirage News2d
Triple Combo Drug Approved for Cystic Fibrosis
In two randomised phase 3 studies involving 480 participants aged 12 years and over, ivacaftor/tezacaftor/vanzacaftor was ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment
Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...
The Pharma Letter2d
MHRA backing for Alyftrek for cystic fibrosis
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Alyftrek (triple combination medicine ...
Arcturus Therapeutics price target lowered to $60 from $63 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $60 from $63 and keeps a Buy rating on the ...
WOODTV.com4d
Friends and Families of Cystic Fibrosis to host fundraiser Masquerade Ball
Approximately 1,000 new cases of Cystic Fibrosis are diagnosed each year that bring costly treatments to many families. The ...
Yahoo Finance12d
Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
University at Buffalo5d
UB and Kaleida Health name Beth Smith chair of psychiatry and chief of service, psychiatry and behavioral medicine
Beth A. Smith, MD, has been appointed chair of the Department of Psychiatry in the Jacobs School of Medicine and Biomedical ...
Independent.ie5d
Crucial gut bacteria is missing in infants with cystic fibrosis, new research shows
Infants with cystic fibrosis lack crucial “beneficial bacteria” in their gut, according to new research. Scientists say this ...